Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
By Francisco Gómez Veiga, Urbano Anido Herranz, Antonio Gómez Caamaño and Benito Rodriguez Iglesias
Publisher: 'Springer Science and Business Media LLC'
Year: 2013
DOI identifier: 10.1038/bjc.2013.270
OAI identifier:
oai:runa.sergas.gal:20.500.11940/904
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the
following location(s):
http://hdl.handle.net/20.500.1... (external
link)